Cargando…
C9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years
The 2011 discovery of the pathogenic hexanucleotide repeat expansion (HRE) in C9orf72, the leading genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), marked a breakthrough in the effort to unravel the etiology of these conditions. Ten years later, clinicians...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862089/ https://www.ncbi.nlm.nih.gov/pubmed/33575483 http://dx.doi.org/10.1212/NXG.0000000000000542 |